Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2293 Views
-
Last post by NHE
-
- 6 Replies
- 6350 Views
-
Last post by ElliotB
-
- 0 Replies
- 1326 Views
-
Last post by NHE
-
- 0 Replies
- 3406 Views
-
Last post by NHE
-
- 1 Replies
- 1016 Views
-
Last post by NHE
-
- 1 Replies
- 1509 Views
-
Last post by NHE
-
- 11 Replies
- 3331 Views
-
Last post by NHE
-
- 0 Replies
- 3154 Views
-
Last post by NHE
-
- 0 Replies
- 1346 Views
-
Last post by NHE